SRSF2 promotes splicing and transcription of exon 11 included isoform in Ron proto-oncogene

Heegyum Moon1, Sunghee Cho1, Tiing Jen Loh1

  • 1School of Life Sciences, Gwangju Institute of Science and Technology, Gwangju 500-712, Republic of Korea.

Insights

SRSF2 regulates the inclusion of exon 11 in the Ron proto-oncogene, affecting its expression. This splicing factor targets exon 11, influencing Ron protein levels and function.

Area of Science:

  • Molecular Biology
  • Gene Regulation
  • Cancer Research

Background:

  • The proto-oncogene Ron encodes a receptor tyrosine kinase involved in cell motility.
  • Aberrant Ron expression, particularly the constitutively active Ron△165 isoform due to exon 11 skipping, is linked to cancer progression.
  • Understanding the regulation of Ron splicing is crucial for deciphering its role in disease.

Purpose of the Study:

  • To investigate the role of SRSF2 (Serine/Arginine-rich splicing factor 2) in regulating Ron pre-mRNA splicing.
  • To elucidate the mechanism by which SRSF2 controls exon 11 inclusion of the Ron gene.
  • To identify the specific sequence and interaction of SRSF2 with Ron exon 11.

Main Methods:

  • RNA interference (knockdown) and overexpression of SRSF2.
  • Analysis of pre-mRNA splicing patterns for Ron exon 11 and introns 10/11.
  • Mutation analysis of SRSF2 binding sites on Ron exon 11.
  • Assessment of SRSF2 physical interaction with target sequences.

Main Results:

  • Knockdown of SRSF2 decreased exon 11 inclusion, while its overexpression enhanced inclusion.
  • SRSF2 influences both splicing and transcription of the Ron gene.
  • SRSF2 directly binds to the CGAG sequence on Ron exon 11, promoting its inclusion.
  • The strength of splice sites flanking exon 11 is not essential for SRSF2-mediated splicing regulation.

Conclusions:

  • SRSF2 is a key regulator of Ron proto-oncogene expression by promoting exon 11 inclusion.
  • SRSF2 targets exon 11 directly, providing a novel mechanism for controlling Ron expression.
  • These findings offer insights into the molecular mechanisms governing oncogene expression and potential therapeutic targets.

Related Concept Videos

RNA Splicing01:32

RNA Splicing

Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
53.2K
RNA Splicing01:32

RNA Splicing

15.8K
Alternative RNA Splicing02:18

Alternative RNA Splicing

Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
20.4K
Alternative RNA Splicing02:18

Alternative RNA Splicing

4.2K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

5.7K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.8K